Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (231-240 of 518) with videos related to

Pageof 52
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 30, 2019
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapyAngelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2022
Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathyDavid Mizrahi, David Goldstein, Matthew C Kiernan, et al.
Psycho-Oncology|July 1, 2015
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health servicesVanessa L Beesley, Monika Janda, David Goldstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2021
Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferencesAlice Yu, Deborah Street, Rosalie Viney, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2021
The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivorsHannah C Timmins, Tiffany Li, David Goldstein, et al.
Asia-Pacific Journal of Clinical Oncology|September 20, 2012
Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionalsPeter Grimison, Fiona Phillips, Phyllis Butow, et al.
Psycho-Oncology|August 14, 2018
Symptom burden in adults with thyroid cancerAnna M Sawka, Sarah Watt, Gary Rodin, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2015
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancerNiall Tebbutt, Dusan Kotasek, Howard A Burris, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 11, 2012
Second free flaps in head and neck reconstructionGary Ross, Tuija M Yla-Kotola, David Goldstein, et al.
Journal of Neuropathology and Experimental Neurology|December 20, 2007
Postmortem delay has minimal effect on brain RNA integrityJohn F Ervin, Erin L Heinzen, Kenneth D Cronin, et al.
Pageof 52

Showing results (231-240 of 518) with videos related to

Sort By:
Pageof 52
Acta Oncologica (Stockholm, Sweden)|August 30, 2019
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapyAngelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2022
Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathyDavid Mizrahi, David Goldstein, Matthew C Kiernan, et al.
Psycho-Oncology|July 1, 2015
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health servicesVanessa L Beesley, Monika Janda, David Goldstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2021
Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferencesAlice Yu, Deborah Street, Rosalie Viney, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2021
The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivorsHannah C Timmins, Tiffany Li, David Goldstein, et al.
Asia-Pacific Journal of Clinical Oncology|September 20, 2012
Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionalsPeter Grimison, Fiona Phillips, Phyllis Butow, et al.
Psycho-Oncology|August 14, 2018
Symptom burden in adults with thyroid cancerAnna M Sawka, Sarah Watt, Gary Rodin, et al.
Cancer Chemotherapy and Pharmacology|March 17, 2015
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancerNiall Tebbutt, Dusan Kotasek, Howard A Burris, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 11, 2012
Second free flaps in head and neck reconstructionGary Ross, Tuija M Yla-Kotola, David Goldstein, et al.
Journal of Neuropathology and Experimental Neurology|December 20, 2007
Postmortem delay has minimal effect on brain RNA integrityJohn F Ervin, Erin L Heinzen, Kenneth D Cronin, et al.
Pageof 52